GTGuojie Teng

Guojie Teng

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Guojie Teng has a total of 10 co-authors. Here are the top co-authors by number of shared publications:

  • Hongjun Liu

    Department of Evidence-Based Medicine, Xuanwu Hospital Capital Medical University, Beijing, China

    2 shared publications
  • Lin Zhang

    Department of Pulmonary and Critical Care Medicine, Xuanwu Hospital Capital Medical University, Xicheng District, Beijing, China

    2 shared publications
  • Ning Wang

    Department of Neurosurgery, Xuanwu Hospital, Capital Medical University, China International Neuroscience Institute (China-INI), Beijing, China

    2 shared publications
  • Xiuhong Nie

    Department of Pulmonary and Critical Care Medicine, Xuanwu Hospital Capital Medical University, Xicheng District, Beijing, China

    2 shared publications
  • Jingshan Bai

    Department of Respiratory Medicine, Xiongan Xuanwu Hospital, Xiongan New Area, Baoding, Hebei, China

    1 shared publication
  • Qian Huang

    Department of Respiratory Medicine, Dazhou Dachuan District People’s Hospital (Dazhou Third People’s Hospital), Dazhou, Sichuan, China

    1 shared publication

Latest Publications

  • Open Access

    Association of Life’s Crucial 9 with all-cause and cardiovascular mortality among the individuals with chronic inflammatory airway diseases

    by Youli Wen, Wenqiang Li, Jingshan Bai, Guojie Teng, Yanlei Ge, Yuting Fan, Qian Huang

    Patients with chronic inflammatory airway diseases (CIAD) have been found to carry a higher burden of cardiovascular diseases. The objective of our research is to explore the link between Life’s Crucial 9 (LC9), a newly introduced measure of cardiovascular health by the American Heart Association, and the risks of all-cause and cardiovascular mortality among patients with CIAD. This prospective cohort study included 2403 patients with CIAD who participated in the National Health and Nutrition Examination Survey from 2007 to 2018. Cox proportional hazards regression models were utilized to calculate the potential associations between LC9 and all-cause mortality and cardiovascular disease mortality in CIAD patients. Restricted cubic spline was employed to estimate possible nonlinear associations. A total of 2403 patients with CIAD were included in the study. The LC9 were divided into 4 quartiles, using the lowest quartile as the reference category for comparison. Following the adjustment for various confounding factors, it was observed that higher LC9 were linked to a reduced risk of all-cause and cardiovascular mortality among the patient population. After adjusting for age, sex, ethnicity, education level, marital status, poverty-to-income ratio, and insurance status, the risk of all-cause mortality decreased by 71% (hazard ratio = 0.29, 95% confidence interval: 0.18–0.49), and the risk of cardiovascular mortality decreased by 87% (hazard ratio = 0.13, 95% confidence interval: 0.05–0.35). Furthermore, the analysis utilizing restricted cubic splines uncovered a nonlinear, positive association between the LC9 scores and mortality rates, including all-cause and cardiovascular mortality, among patients with CIAD. This research indicates that elevated LC9 scores are linked to a lower likelihood of all-cause and cardiovascular mortality in individuals suffering from CIAD.

  • Open Access

    Analysis of risk factors for early-onset ventilator-associated pneumonia in a neurosurgical intensive care unit

    by Guojie Teng, Ning Wang, Xiuhong Nie, Lin Zhang, Hongjun Liu

    Background: Ventilator-associated pneumonia (VAP) is a severe infection among patients in the neurosurgery intensive care unit (NICU). Methods: We retrospectively evaluated risk factors for early-onset ventilator-associated pneumonia (EOVAP) from January 2019 to December 2019 at a NICU. A total of 89 NICU patients who were intubated within 48 h of onset and whose mechanical ventilation time was at least 7 days were enrolled. We evaluated EOVAP that occurred within the first 7 days after the onset of mechanical ventilation. The enrolled patients had no history of chronic lung disease and no clinical manifestations of infection before intubation. Clinical data of patients were recorded, and the incidence of and risk factors for EOVAP were analyzed. Patients were also grouped by age (≥ 65 vs. < 65 years) and whether they had received hypothermia treatment or not. Results: Among 89 mechanically ventilated patients (49 men and 40 women; the mean age ± SD was 60.1 ± 14.3 years), 40 patients (44.9%) developed EOVAP within 7 days and 14 patients (15.7%) had a multidrug resistant bacterial infection. Binary logistic regression analysis indicated that older age (≥ 65 years) (odds ratio [OR]:3.53, 95% confidence interval [CI]:1.27–9.79, P = 0.015) and therapeutic hypothermia (OR:3.68, CI:1.10–12.31, p = 0.034) were independent predictors of EOVAP. Levels of peripheral blood leukocytes, neutrophils and platelets were lower in the therapeutic hypothermia group than those who did not receive hypothermia treatment. Conclusions: This study found that older age (≥ 65 years) and therapeutic hypothermia were independently associated with the risk of EOVAP in NICU patients.


  • Open Access

    Analysis of Risk Factors for Early-onset Ventilator-associated Pneumonia in a Neurosurgical Intensive Care Unit: A Single-center Retrospective Study

    by Guojie Teng, Ning Wang, Xiuhong Nie, Lin Zhang, Hongjun Liu

    Background:Ventilator-associated pneumonia (VAP) is a severe infection among patients in the neurosurgery intensive care unit (NICU).Methods:We retrospectively evaluated risk factors for early-onset ventilator-associated pneumonia (EOVAP) from January 2019 to December 2019 at a NICU. A total of 89 NICU patients who were intubated within 48 hours of onset and whose mechanical ventilation time was longer than 7 days were enrolled. The enrolled patients had no history of chronic lung disease and no clinical manifestations of infection before intubation. Clinical data of patients were recorded, and the incidence of and risk factors for EOVAP were analyzed. Patients were also grouped by age (≥65 vs. Results:Among 89 mechanically ventilated patients (49 men and 40 women; median age 60.1±14.3 years), 40 patients (44.9%) developed EOVAP in 7 days and 14 patients (15.7%) had multidrug resistant bacteria. Binary logistic regression analysis indicated that older age (≥65years) (odds ratio [OR]: 0.267, 95% confidence interval [CI]: 0.101-0.709, P=0.008) and therapeutic hypothermia (OR: 0.235, CI: 0.075-0.738, p=0.013) were independent predictors of EOVAP. Levels of peripheral blood leukocytes, neutrophils and platelets were lower in the therapeutic hypothermia group than those that did not receive hypothermia treatment.Conclusions:This study found that older age (≥65years) and therapeutic hypothermia were independently associated with the risk of EOVAP in NICU patients.